ATHA - Athira Pharma  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Athira Pharma 's activity chart (see below) currently has 5 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 96.75 days.

Most recent stock forecast was given by from MIZUHO on 19-Sep-2024.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Jul-2022

$5

$-2.66 (-34.73%)

$500

1 years 11 months 28 days ago
(19-Sep-2024)

2/4 (50%)

$0.35 (7.53%)

251

Hold Since 04-Sep-2024

2 years 12 days ago
(04-Sep-2024)

0/1 (0%)

$325.6 (176.57%)

Hold Since 04-Sep-2024

$100

2 years 12 days ago
(04-Sep-2024)

0/2 (0%)

$75.4 (306.50%)

Hold Since 23-Jun-2022

$30

$22.34 (291.64%)

$32

4 years 2 months 24 days ago
(23-Jun-2022)

5/5 (100%)

$2.5 (9.09%)

210

Buy Since 13-Oct-2020

4 years 2 months 24 days ago
(23-Jun-2022)

0/1 (0%)

$175.6 (95.23%)

Show more analysts

Please expand the browser size to see the chart

What is ATHA (Athira Pharma ) average time for price targets to be met?

On average it took 97 days for the stock forecasts to be reached, with an average price target met ratio of 37.5%.

Which analyst most recently updated their price target on ATHA (Athira Pharma )?

Which analyst has the most public recommendations on ATHA (Athira Pharma )?

has 0 price targets and 0 ratings on ATHA

Which analyst is the currently most bullish on ATHA (Athira Pharma )?

Corinne Jenkins with the highest potential upside of $1592.34

Which analyst is the currently most reserved on ATHA (Athira Pharma )?

Graig Suvannavejh with the lowest potential downside of -$2.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?